"hypercoagulative" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "hyper",
        "3": "coagulative"
      },
      "expansion": "hyper- + coagulative",
      "name": "prefix"
    }
  ],
  "etymology_text": "hyper- + coagulative",
  "forms": [
    {
      "form": "more hypercoagulative",
      "tags": [
        "comparative"
      ]
    },
    {
      "form": "most hypercoagulative",
      "tags": [
        "superlative"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {},
      "expansion": "hypercoagulative (comparative more hypercoagulative, superlative most hypercoagulative)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with hyper-",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 July 29, Carville G. Bevans et al., “Phylogeny of the Vitamin K 2,3-Epoxide Reductase (VKOR) Family and Evolutionary Relationship to the Disulfide Bond Formation Protein B (DsbB) Family”, in Nutrients, volume 7, →DOI",
          "text": "In the case of pathological hypercoagulative conditions such as thrombosis and embolism, 4-hydroxycoumarin based oral anticoagulants, including warfarin as a well-known example, are administered to block the enzymatic function of VKORC1, effectively diminishing turnover of the vitamin K cycle.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Involving excessive coagulation."
      ],
      "id": "en-hypercoagulative-en-adj-EwDeWgWD",
      "links": [
        [
          "coagulation",
          "coagulation"
        ]
      ]
    }
  ],
  "word": "hypercoagulative"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "hyper",
        "3": "coagulative"
      },
      "expansion": "hyper- + coagulative",
      "name": "prefix"
    }
  ],
  "etymology_text": "hyper- + coagulative",
  "forms": [
    {
      "form": "more hypercoagulative",
      "tags": [
        "comparative"
      ]
    },
    {
      "form": "most hypercoagulative",
      "tags": [
        "superlative"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {},
      "expansion": "hypercoagulative (comparative more hypercoagulative, superlative most hypercoagulative)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with hyper-",
        "English terms with quotations"
      ],
      "examples": [
        {
          "ref": "2015 July 29, Carville G. Bevans et al., “Phylogeny of the Vitamin K 2,3-Epoxide Reductase (VKOR) Family and Evolutionary Relationship to the Disulfide Bond Formation Protein B (DsbB) Family”, in Nutrients, volume 7, →DOI",
          "text": "In the case of pathological hypercoagulative conditions such as thrombosis and embolism, 4-hydroxycoumarin based oral anticoagulants, including warfarin as a well-known example, are administered to block the enzymatic function of VKORC1, effectively diminishing turnover of the vitamin K cycle.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Involving excessive coagulation."
      ],
      "links": [
        [
          "coagulation",
          "coagulation"
        ]
      ]
    }
  ],
  "word": "hypercoagulative"
}